EUVIMEDOpdag EUVIMED
KohortenstudieOpen access · CC BY-NC-ND 4.0

Post‐Thyroidectomy Opioid Prescription and Risk of Persistent Opioid Use: A Propensity Matched Cohort Study

Oluwatobiloba Ayo-Ajibola iD, Milan P Fehrenbach iD, Asher C Park iD, Jonathan D West iD, Daniel I Kwon iD

Head & Neck · 2025

DOI: 10.1002/hed.28232 ↗

At a glance

Kohortenstudie in Head & Neck, 2025. Written by Oluwatobiloba Ayo-Ajibola and 4 co-authors. Institution: Keck School of Medicine of the University of Southern California, Los Angeles, California, USA. Major MEDLINE topics: Thyroidectomy, Analgesics, Opioid, Postoperative Pain, Opioid-Related Disorders. 79 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

This study evaluates the risk of persistent opioid use (POU) among thyroidectomy patients given postoperative opioids.

Methods

Patients undergoing thyroidectomy were identified using the TriNetX Research Platform (2010–2024). Cohorts were divided based on opioid prescriptions on the day of surgery. With propensity score matching to prevent confounding bias, risk ratios were calculated for opioid prescriptions 3–9 months post‐surgery. Secondary outcomes included ED presentation, pain diagnosis, and lifetime risk of opioid use disorder, defined as significant social dysfunction due to uncontrolled use.

Results

The post‐match opioid group ( n = 19,727) experienced a 4.61% risk of POU (control: 4.07%), representing a 14% higher risk of POU compared to the non‐opioid group (RR 1.14, 95% CI: [1.03, 1.25]). Opioids slightly decreased the likelihood of outpatient visits at 30 days (RR: 0.97 [0.95, 0.98]) and 90 days (RR: 0.96 [0.94, 0.97]) following surgery. There were no significant differences in ED presentation, pain diagnoses at 30 and 90 days, or lifetime OUD risk.

Conclusion

Post‐thyroidectomy opioid prescription modestly increases POU risk, highlighting the need for careful patient counseling and judicious use.

Subjects

MeSH terms (MEDLINE)

ThyroidectomyAnalgesics, OpioidPostoperative PainOpioid-Related DisordersHumansFemaleMalePropensity ScoreMiddle AgedAdultRetrospective StudiesDrug PrescriptionsCohort StudiesAgedRisk Assessment

Author keywords

endocrine surgical proceduresopioidsopioid‐related disorderspostoperative painthyroidectomy

Substances

Analgesics, Opioid

Authors and institutions

  • Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
  • University of Kentucky College of Medicine, Lexington, Kentucky, USA.
  • Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Caruso Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.

ORCID profiles: Oluwatobiloba Ayo-Ajibola, Milan P Fehrenbach, Asher C Park, Jonathan D West, Daniel I Kwon

Cite

APA

Ayo-Ajibola, O., Fehrenbach, M. P., Park, A. C., West, J. D., & Kwon, D. I. (2025). Post‐Thyroidectomy Opioid Prescription and Risk of Persistent Opioid Use: A Propensity Matched Cohort Study. Head & Neck. https://doi.org/10.1002/hed.28232

Vancouver

Ayo-Ajibola O, Fehrenbach MP, Park AC, West JD, Kwon DI. Post‐Thyroidectomy Opioid Prescription and Risk of Persistent Opioid Use: A Propensity Matched Cohort Study. Head & Neck. 2025. doi:10.1002/hed.28232

BibTeX
@article{AyoAjibola2025,
  author = {Ayo-Ajibola, Oluwatobiloba and Fehrenbach, Milan P and Park, Asher C and West, Jonathan D and Kwon, Daniel I},
  title = {Post‐Thyroidectomy Opioid Prescription and Risk of Persistent Opioid Use: A Propensity Matched Cohort Study},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.28232}
}
Start for free →